Baxter International Inc (BAX) stock
BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$26.16+0.40 (+1.55%)
Close on Nov 18, 2026Market cap $13.53BP/E –Yield 1.99%
Baxter International operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Baxter International's operating income for the twelve months ending Sep 30, 2026 was -$221.00M. For fiscal 2025 it was -$308.00M, down 2300.0% from the year before. The highest annual figure on record is $1.77B in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$308.00M | -2300.0% |
| FY2024 | Dec 31, 2024 | $14.00M | -98.0% |
| FY2023 | Dec 31, 2023 | $707.00M | – |
| FY2022 | Dec 31, 2022 | -$2.85B | -310.7% |
| FY2021 | Dec 31, 2021 | $1.35B | -16.5% |
| FY2020 | Dec 31, 2020 | $1.62B | -8.8% |
| FY2019 | Dec 31, 2019 | $1.77B | +11.9% |
| FY2018 | Dec 31, 2018 | $1.58B | +23.0% |
| FY2017 | Dec 31, 2017 | $1.29B | +72.9% |
| FY2016 | Dec 31, 2016 | $745.00M | +65.9% |
| FY2015 | Dec 31, 2015 | $449.00M | -31.6% |
| FY2014 | Dec 31, 2014 | $656.00M | +32.3% |
| FY2013 | Dec 31, 2013 | $496.00M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $225.00M | +30.8% |
| Q2 FY2026 | Jun 30, 2026 | $217.00M | +13.6% |
| Q1 FY2026 | Mar 31, 2026 | $66.00M | +13.8% |
| Q4 FY2025 | Dec 31, 2025 | -$729.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $172.00M | +11.0% |
| Q2 FY2025 | Jun 30, 2025 | $191.00M | +6.7% |
| Q1 FY2025 | Mar 31, 2025 | $58.00M | -49.6% |
| Q4 FY2024 | Dec 31, 2024 | -$435.00M | -243.1% |
| Q3 FY2024 | Sep 30, 2024 | $155.00M | -13.4% |
| Q2 FY2024 | Jun 30, 2024 | $179.00M | – |
| Q1 FY2024 | Mar 31, 2024 | $115.00M | -10.9% |
| Q4 FY2023 | Dec 31, 2023 | $304.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $179.00M | – |
| Q2 FY2023 | Jun 30, 2023 | -$17.00M | -106.4% |
| Q1 FY2023 | Mar 31, 2023 | $129.00M | -20.9% |
| Q4 FY2022 | Dec 31, 2022 | -$312.00M | -1456.5% |
| Q3 FY2022 | Sep 30, 2022 | -$2.88B | -661.4% |
| Q2 FY2022 | Jun 30, 2022 | $264.00M | -37.7% |
| Q1 FY2022 | Mar 31, 2022 | $163.00M | -58.2% |
| Q4 FY2021 | Dec 31, 2021 | $23.00M | -94.3% |
| Q3 FY2021 | Sep 30, 2021 | $513.00M | +9.1% |
| Q2 FY2021 | Jun 30, 2021 | $424.00M | +28.1% |
| Q1 FY2021 | Mar 31, 2021 | $390.00M | -4.6% |
| Q4 FY2020 | Dec 31, 2020 | $406.00M | -24.3% |
| Q3 FY2020 | Sep 30, 2020 | $470.00M | -6.6% |
| Q2 FY2020 | Jun 30, 2020 | $331.00M | -5.4% |
| Q1 FY2020 | Mar 31, 2020 | $409.00M | +6.8% |
| Q4 FY2019 | Dec 31, 2019 | $536.00M | +37.1% |
| Q3 FY2019 | Sep 30, 2019 | $503.00M | +31.7% |
| Q2 FY2019 | Jun 30, 2019 | $350.00M | -7.2% |
| Q1 FY2019 | Mar 31, 2019 | $383.00M | -11.8% |
| Q4 FY2018 | Dec 31, 2018 | $391.00M | +35.8% |
| Q3 FY2018 | Sep 30, 2018 | $382.00M | +27.3% |
| Q2 FY2018 | Jun 30, 2018 | $377.00M | +8.6% |
| Q1 FY2018 | Mar 31, 2018 | $434.00M | +22.9% |
| Q4 FY2017 | Dec 31, 2017 | $288.00M | -5.0% |
| Q3 FY2017 | Sep 30, 2017 | $300.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $347.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $353.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $303.00M | – |
See a number that looks wrong?